Navigation Links
Mood-Enhancing and Heart Health Foods Emerging as Incidence of Heart Diseases Rises
Date:1/15/2009

LITTLE FALLS, N.J., Jan. 15 /PRNewswire/ -- As today's aging population spends increasing amounts on prevention rather than cures, the market for mood-enhancing foods will continue to experience healthy growth rates, according to the latest research from worldwide consulting and research firm Kline & Company (http://www.klinegroup.com).

While the functional foods industry has so far focused mainly on physical benefits and health claims, mood, emotional, and cognitive health claims are emerging to form an important new market segment, according to Kline's FlashPoint report titled Mood-Enhancing Foods and Beverages: The "Fun" in Functional Foods (http://www.klinegroup.com/reports/f0802.asp).

Where functional foods and beverages are broadly defined as fortified and enhanced products that offer additional health benefits beyond nutrition, "mood foods" are products that claim to uplift mood, boost mental health, or improve cognitive functions by stimulating brain chemicals known as neurotransmitters.

Kline's FlashPoint report focuses specifically on opportunities and challenges in the mood foods market segment, while another report due to be published later this year, titled Global Functional Foods and Beverages 2009: Heart Health Market Analysis and Opportunities (http://www.klinegroup.com/reports/y670.asp), examines the broader market in terms of heart health.

"Increased consumer demand, the rising incidence of heart disease, a need for cost-effective treatment options, and aging populations worldwide are expected to drive the global markets for functional foods over the next five years," says Laura Mahecha, healthcare industry manager at Kline.

Mood foods compete directly with a number of dietary supplements that make claims of stress and anxiety reduction and mood enhancement. However, the supplements market contains a plethora of products with unsubstantiated claims and dubious ingredients. Mood foods that are able to furnish scientifically-based, proven claims of efficacy are more likely to realize commercial success.

Mood-Enhancing Foods and Beverages: The "Fun" in Functional Foods (http://www.klinegroup.com/reports/f0802.asp) analyses opportunities, challenges, and key factors for success; examines types of mood-enhancing foods and beverages and their ingredients; and explores innovation in this high-growth segment.

Global Functional Foods and Beverages 2009: Heart Health Market Analysis and Opportunities (http://www.klinegroup.com/reports/y670.asp) will examine company- and brand-level sales, innovation and new product trends, regulatory impacts on claims, retail trends, and forecasts to 2013. The report will focus on products that contain heart health components, including EGCG, omega-3 fatty acids, fiber, plant sterols and stanols, polyphenols, reservatrol, and vitamin D.

About Kline

Kline is a worldwide consulting and research firm dedicated to providing the kind of insight and knowledge that helps companies find a clear path to success. The firm has served the management consulting and market research needs of organizations in the chemicals, materials, energy, life sciences, and consumer products industries for nearly 50 years. For more information, visit www.KlineGroup.com.

    For more information, contact:
    Vera Sandarova
    Marketing Communications
    +420-222-316-282
    Vera.Sandarova@klinegroup.com


'/>"/>
SOURCE Kline & Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HPS Files Patent for Mood-Enhancing Compound Naturally Found in Sea Coral
2. Drug for cluster headaches may cause heart problems
3. Use of certain lipid measures not more effective in predicting coronary heart disease
4. Restricting Blood Flow May Help Heart Bypass Patients
5. Urban Smog Tough on Young Adults Hearts
6. Stanford study highlights cost-effective method of lowering heart disease risks
7. Vitamin Es lack of heart benefit linked to dosage
8. Drug That Lowers Resting Heart Rate Being Tested
9. Heart Attack Boosts Diabetes Risk
10. Embryonic Stem Cells Repair Human Heart
11. U of M study: Early treatment can reverse heart damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: